New Enterprise Associates 15, L.P. is > 10% Shareholder of Arcellx, Inc.. Currently has a direct ownership of 4.75 Million shares of ACLX, which is worth approximately $271 Million. The most recent transaction as insider was on Dec 20, 2022, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.75M
0% 3M change
0% 12M change
Total Value Held $271 Million

New Enterprise Associates 15, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 20 2022
SELL
Other acquisition or disposition
-
2,000,000 Reduced 29.65%
4,745,262 Common Stock
Jun 21 2022
BUY
Open market or private purchase
$5,000,000 $16.0 p/Share
312,500 Added 4.43%
6,745,262 Common Stock
Feb 08 2022
BUY
Conversion of derivative security
-
4,849,429 Added 50.0%
4,849,429 Common Stock
Feb 08 2022
BUY
Open market or private purchase
$23,749,995 $15.0 p/Share
1,583,333 Added 19.75%
6,432,762 Common Stock

Also insider at

EAR
Eargo, Inc. Healthcare
RPHM
Reneo Pharmaceuticals, Inc. Healthcare
DM
Desktop Metal, Inc. Technology
BHG
Bright Health Group Inc. Healthcare
HOOD
Robinhood Markets, Inc. Technology
IONQ
IonQ, Inc. Technology
AVEO
AVEO PHARMACEUTICALS, INC. Healthcare
BGRY
Berkshire Grey, Inc. Industrials
NEA

New Enterprise Associates 15, L.P.

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on ACLX

Follow Arcellx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACLX shares.

Notify only if

Insider Trading

Get notified when an Arcellx, Inc. insider buys or sells ACLX shares.

Notify only if

News

Receive news related to Arcellx, Inc.

Track Activities on ACLX